Zacks currently has a $16 target price on the stock. Boston Scientific traded up 0.83 percent during mid-day trading on Friday, Feb. 6, hitting $14.57. The stock had a trading volume of 1.4 million shares. The company has a 52-week low of $11.10 and a 52 week-high of $15.28, according to the report.
More articles on GI/endoscopy:
The Children’s Hospital at Montefiore opens pediatric fatty liver disease clinic
Dr. Purvi Panchal joins Pennsylvania Gastroenterology Consultants
Greater Gaston Endoscopy Center officially opens in North Carolina: 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
